Organic Acidemia – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Organic Acidemia – Drugs In Development, 2024 report and make more profitable business decisions.
Organic acidemia or organic acidurias are a group of inherited metabolic disorders characterized by the accumulation of abnormal organic acid metabolites in the body fluids and tissues. They are caused by a deficiency in an enzyme necessary to break down amino acids, thus causing increased organic acids in body fluids that are then excreted in urine. Vomiting, poor feeding, failure to thrive, hypoglycemia, hyperammonemia, seizures, hypotonia, lethargy, coma, apnea, and respiratory distress are the symptoms of organic acidemia. The most common test for diagnosing organic acidemia is urine organic acid analysis. Levocarnitine and glycine medications, a restricted protein diet and amino acid supplements, and increasing calories and fluids are treatment options.
The Organic Acidemia drugs in development market research report provide comprehensive information on the therapeutics under development for Organic Acidemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Organic Acidemia and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Organic Acidemia | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 5 molecules, with 5 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Organic Acidemia therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Organic Acidemia pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Organic Acidemia treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Organic Acidemia reports